Every pandemic is different. Nevertheless, certain commonalities can be identified across all pandemics. Researchers at the Max Planck Institute for Dynamics and Self-Organization (MPI-DS), together ...

World Health Organization officials first learned about a cluster of cases of pneumonia in the Hubei Province of China on Dec. 31, 2019. This represented the initial report of what soon became known ...

COVID-19 has exposed humankind’s weaknesses, vulnerabilities and interdependencies – not least in Latin America, where, at the time of writing in late May, infection rates and mortality are rising ...

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has published principles for evaluating COVID-19 vaccines. The principles echo guidelines published in other parts of the world, for example ...

As organizations address the longer-term implications of COVID-19, Yann Zopf of the World Economic Forum says it is imperative to focus on the needs of all stakeholders, from customers to suppliers to ...

Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...

COVID-19 is a respiratory disease. Yet, from the earliest days of the pandemic, the cardiovascular risks associated with SARS-CoV-2 infection were clear: individuals with severe cases of COVID-19 ...